These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15829199)

  • 1. Childhood hemolytic uremic syndrome, United Kingdom and Ireland.
    Lynn RM; O'Brien SJ; Taylor CM; Adak GK; Chart H; Cheasty T; Coia JE; Gillespie IA; Locking ME; Reilly WJ; Smith HR; Waters A; Willshaw GA
    Emerg Infect Dis; 2005 Apr; 11(4):590-6. PubMed ID: 15829199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemolytic uraemic syndrome in children admitted to a rural district hospital in Kenya.
    Olotu AI; Mithwani S; Newton CR
    Trop Doct; 2008 Jul; 38(3):165-7. PubMed ID: 18628547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial incidence of hemolytic uremic syndrome.
    Jernigan SM; Waldo FB
    Pediatr Nephrol; 1994 Oct; 8(5):545-7. PubMed ID: 7818999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic uremic syndrome: Events of the past decade.
    McLaine PN
    Paediatr Child Health; 2002 Oct; 7(8):533-7. PubMed ID: 20046465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012.
    Byrne L; Jenkins C; Launders N; Elson R; Adak GK
    Epidemiol Infect; 2015 Dec; 143(16):3475-87. PubMed ID: 25920912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.
    Michael M; Elliott EJ; Ridley GF; Hodson EM; Craig JC
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD003595. PubMed ID: 19160220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature.
    Scheutz F; Teel LD; Beutin L; Piérard D; Buvens G; Karch H; Mellmann A; Caprioli A; Tozzoli R; Morabito S; Strockbine NA; Melton-Celsa AR; Sanchez M; Persson S; O'Brien AD
    J Clin Microbiol; 2012 Sep; 50(9):2951-63. PubMed ID: 22760050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Shiga Toxin-Producing
    Fitzgerald SF; Mitchell MC; Holmes A; Allison L; Chase-Topping M; Lupolova N; Wells B; Gally DL; McNeilly TN
    Animals (Basel); 2023 Sep; 13(17):. PubMed ID: 37685059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: A prospective cohort study.
    Byrne L; Douglas A; Launders N; Godbole G; Lynn R; Inward C; Jenkins C
    Epidemiol Infect; 2023 Sep; 151():e160. PubMed ID: 37655611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement.
    Wildes DM; Harvey S; Costigan CS; Sweeney C; Twomey É; Awan A; Gorman KM
    Pediatr Nephrol; 2024 Jan; 39(1):315-324. PubMed ID: 37491519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and Outcomes of Hospitalizations Due to Hemolytic Uremic Syndrome: A National Perspective.
    Lingas E; Mulayamkuzhiyil Saju J; Abdulqader MA; Yolmo D; Shaikh M; Rupasinghe PCD; Patel AA
    Cureus; 2022 Dec; 14(12):e32315. PubMed ID: 36628001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HUS with mutations in CFH and STEC infection treated with eculizumab in a 4-year-old girl.
    Galvez C; Krall P; Rojas A; Oh J; Cano F
    Pediatr Nephrol; 2023 Apr; 38(4):1195-1203. PubMed ID: 35969277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of Shiga toxin-producing
    Butt S; Jenkins C; Godbole G; Byrne L
    Epidemiol Infect; 2022 Feb; 150():e52. PubMed ID: 35241189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study.
    Myojin S; Pak K; Sako M; Kobayashi T; Takahashi T; Sunagawa T; Tsuboi N; Ishikura K; Kubota M; Kubota M; Igarashi T; Morioka I; Miyairi I
    PLoS One; 2022; 17(2):e0263349. PubMed ID: 35120154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AB
    Biernbaum EN; Kudva IT
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of neurological involvement in patients with/without diarrhea hemolytic uremic syndrome: A Systematic review and meta-analysis.
    Tavasoli A; Zafaranloo N; Hoseini R; Otukesh H; Nakhaiee S
    Med J Islam Repub Iran; 2021; 35():91. PubMed ID: 34956937
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurological involvement in children with hemolytic uremic syndrome.
    Costigan C; Raftery T; Carroll AG; Wildes D; Reynolds C; Cunney R; Dolan N; Drew RJ; Lynch BJ; O'Rourke DJ; Stack M; Sweeney C; Shahwan A; Twomey E; Waldron M; Riordan M; Awan A; Gorman KM
    Eur J Pediatr; 2022 Feb; 181(2):501-512. PubMed ID: 34378062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine.
    Agarwal HS; Latifi SQ
    Pathogens; 2021 Jun; 10(6):. PubMed ID: 34207609
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence of on-going transmission of Shiga toxin-producing
    Butt S; Smith-Palmer A; Shand A; McDonald E; Allison L; Maund J; Fernandes A; Vishram B; Greig DR; Jenkins C; Elson R;
    Epidemiol Infect; 2021 Jun; 149():e147. PubMed ID: 34096488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Characterization of the Enterohemolysin Gene (
    Hua Y; Zhang J; Jernberg C; Chromek M; Hansson S; Frykman A; Xiong Y; Wan C; Matussek A; Bai X
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33477906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.